These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 6308617)

  • 1. Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils.
    Ham EA; Soderman DD; Zanetti ME; Dougherty HW; McCauley E; Kuehl FA
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4349-53. PubMed ID: 6308617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.
    Rollins TE; Zanolari B; Springer MS; Guindon Y; Zamboni R; Lau CK; Rokach J
    Prostaglandins; 1983 Feb; 25(2):281-9. PubMed ID: 6304818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes.
    Kreisle RA; Parker CW
    J Exp Med; 1983 Feb; 157(2):628-41. PubMed ID: 6296265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of leukotriene B4 from human neutrophils measured by specific radioimmunoassay.
    Salmon JA; Simmons PM; Palmer RM
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():215-20. PubMed ID: 6303069
    [No Abstract]   [Full Text] [Related]  

  • 5. Potent inhibition of leukotriene (LT) B4 release from human polymorphonuclear leukocytes (PMN) by the PGE1-analogue OP-1206.
    Ney P; Hecker G; Schröder H; Schrör K
    Biomed Biochim Acta; 1988; 47(10-11):S186-9. PubMed ID: 2470354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers.
    Yuli I; Tomonaga A; Synderman R
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5906-10. PubMed ID: 6310554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired leukotriene B4 release by neonatal polymorphonuclear leukocytes.
    Viggiano D; Romano G; Caniglia M; Santoro P; Palumbo A; Ciccimarra F
    Pediatr Res; 1994 Jul; 36(1 Pt 1):60-3. PubMed ID: 7936838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulus-dependent inhibition of superoxide generation by prostaglandins.
    Sedgwick JB; Berube ML; Zurier RB
    Clin Immunol Immunopathol; 1985 Feb; 34(2):205-15. PubMed ID: 2981649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin 1(1) (U-60,257), an inhibitor of leukotriene synthesis, on human neutrophil function.
    Smith RJ; Sun FF; Bowman BJ; Iden SS; Smith HW; McGuire JC
    Biochem Biophys Res Commun; 1982 Dec; 109(3):943-9. PubMed ID: 6297495
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual effect of phorbol myristate acetate on chemoattractant-induced locomotion of human neutrophils.
    Gaudry M; Marquetty C; Hakim J
    Nouv Rev Fr Hematol (1978); 1990; 32(3):191-8. PubMed ID: 2170935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187.
    Palmer RM; Salmon JA
    Immunology; 1983 Sep; 50(1):65-73. PubMed ID: 6309653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoattractant-elicited alterations of cAMP levels in human polymorphonuclear leukocytes require a Ca2+-dependent mechanism which is independent of transmembrane activation of adenylate cyclase.
    Verghese MW; Fox K; McPhail LC; Snyderman R
    J Biol Chem; 1985 Jun; 260(11):6769-75. PubMed ID: 2581959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness.
    Harvath L; Robbins JD; Russell AA; Seamon KB
    J Immunol; 1991 Jan; 146(1):224-32. PubMed ID: 1701793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cytosolic free calcium and phospholipase C in leukotriene-B4-stimulated secretion in human neutrophils. Comparison with the chemotactic peptide formyl-methionyl-leucyl-phenylalanine.
    Lew PD; Monod A; Waldvogel FA; Pozzan T
    Eur J Biochem; 1987 Jan; 162(1):161-8. PubMed ID: 3028787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of oxygen metabolites from chemoattractant-stimulated neutrophils is inhibited by resting platelets: role of extracellular adenosine and actin polymerization.
    Bengtsson T; Zalavary S; Stendahl O; Grenegård M
    Blood; 1996 May; 87(10):4411-23. PubMed ID: 8639803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGD2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils.
    Ney P; Schrör K
    Eicosanoids; 1991; 4(1):21-8. PubMed ID: 1647806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of leukotriene B4-specific binding and function in rat polymorphonuclear leukocytes: absence of a chemotactic response.
    Kreisle RA; Parker CW; Griffin GL; Senior RM; Stenson WF
    J Immunol; 1985 May; 134(5):3356-63. PubMed ID: 2984287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective defect in human neutrophil superoxide anion generation elicited by the chemoattractant N-formylmethionylleucylphenylalanine in pregnancy.
    Cotton DJ; Seligmann B; O'Brien WF; Gallin JI
    J Infect Dis; 1983 Aug; 148(2):194-9. PubMed ID: 6310000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.